文献速递泌尿生殖腹部US

彩色多普勒血流成像、微血流成像与超声造影在实性肾肿瘤中的诊断效能比较

Comparative Diagnostic Performance of Color Doppler Flow Imaging, MicroFlow Imaging and Contrast-enhanced Ultrasound in Solid Renal Tumors.
PubMed 文献 · Acad Radiol · 2025-01-17

该回顾性研究纳入2020年1月至2022年12月间291例患者共300个经病理证实的实性肾肿瘤,术前均行CDFI、MFI和CEUS检查。MFI在血流分级和血管形态显示上显著优于CDFI,且MFI与CEUS鉴别肾肿瘤良恶性的诊断效能均高于CDFI,MFI与CEUS之间无显著差异。

要点

  • MFI显示血流分级2、3级及血管形态IV、V级的病灶占81%,显著高于CDFI的49%。
  • MFI与CEUS的AUC分别为0.838和0.788,均高于CDFI的0.695。
  • CEUS的廓清、增强强度、廓清及环状增强在良恶性病灶间差异均有统计学意义。

核心结论

  • MFI检测肾肿瘤微血管征象的敏感度高于CDFI,且MFI鉴别肾肿瘤良恶性的诊断效能与CEUS相当。

研究设计与样本

  • 回顾性分析2020年1月至2022年12月间291例患者共300个经病理证实的实性肾肿瘤,术前均行CDFI、MFI和CEUS检查,以病理为参考标准。

关键影像表现/征象

  • MFI识别出243个病灶(81%)具有血流分级2、3级及血管形态IV、V级,CDFI仅检出147例(49%)。
  • CEUS检查中,良恶性肾病灶在造影剂廓清、增强强度、廓清及病灶周围环状增强方面差异均有统计学意义(均p < 0.001)。

诊断标准与关键数值

  • MFI与CEUS的AUC分别为0.838和0.788,均高于CDFI的0.695。
  • 诊断准确率:CDFI 0.600 vs MFI 0.893 vs CEUS 0.920。
  • 敏感度:CDFI 0.554 vs MFI 0.920 vs CEUS 0.984。
  • 特异度:CDFI 0.837 vs MFI 0.755 vs CEUS 0.592。
  • 阳性预测值:CDFI 0.946 vs MFI 0.951 vs CEUS 0.925;阴性预测值:CDFI 0.268 vs MFI 0.649 vs CEUS 0.879。

临床应用与阅片要点

  • MFI与CEUS鉴别实性肾肿瘤良恶性的AUC均高于CDFI,两者间无显著差异(p = 0.075)。
  • MFI与CEUS在诊断实性肾肿瘤方面与CDFI相比差异有统计学意义(p < 0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Accurate distinguish malignant from benign renal masses remains a challenge for radiologists. The purpose of this study was to evaluate the value of Color Doppler Flow Imaging (CDFI), MicroFlow Imaging (MFI) and Contrast-enhanced Ultrasound (CEUS) in diagnosing solid renal tumors.

MATERIALS AND METHODS: A total of 291 patients with 300 solid renal tumors pathologically confirmed were retrospectively analyzed between January 2020 and December 2022. Each patient underwent CDFI, MFI, and CEUS examinations before surgery. The diagnostic efficacy of CDFI, MFI and CEUS in assessing renal tumors was compared based on blood flow grade, vascular morphology and CEUS characteristics.

RESULTS: MFI identified 243 renal lesions (81%) with blood flow grade (2, 3) and vascular morphology (IV, V), significantly outperforming CDFI, which detected 147 cases (49%). MFI demonstrated statistically significant differences in detecting blood flow signals and predicting renal malignancy compared to CDFI (p < 0.001). In CEUS examination, significant differences were observed in wash-in, enhancement intensity, wash-out, and perilesional rim-like enhancement of the contrast agent between malignant and benign renal lesions (all p < 0.001). The areas under the receiver operating characteristic curves (AUCs) for MFI and CEUS were 0.838 and 0.788, respectively, both higher than that for CDFI (0.695). In diagnosing solid renal tumors, MFI and CEUS showed significant differences compared to CDFI (p < 0.05), although no significant difference was found between MFI and CEUS (p = 0.075). The diagnostic accuracy, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of CDFI, MFI and CEUS were as follows: 0.600 vs.0.893 vs.0.920; 0.554 vs. 0.920 vs.0.984; 0.837 vs. 0.755 vs.0.592; 0.946 vs. 0.951 vs.0.925; 0.268 vs. 0.649 vs.0.879.

CONCLUSION: MFI demonstrates higher sensitivity in detecting microvascular signs of renal tumors compared to CDFI. Moreover, MFI exhibits comparable diagnostic performance to CEUS in distinguishing malignant from benign renal masses.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Li C, Qi L, Geng C, et al. Comparative Diagnostic Performance of Color Doppler Flow Imaging, MicroFlow Imaging and Contrast-enhanced Ultrasound in Solid Renal Tumors. Acad Radiol. 2025. PMID: 39826999. doi:10.1016/j.acra.2024.12.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。